Christian Wandersee und Financing - Info zur Person

(1 - 8 von 10

)

vasopharm closes € 9.5 million financing roundBayern Kapital

bayernkapital.de

— Christian Wandersee, CEO von vasopharm, kommentierte: „Nach der Empfehlung des Data Monitoring Committee (DMC), die NOSTRA-III-Studie — Christian Wandersee, CEO von vasopharm, kommentierte: „Nach der Empfehlung des Data Monitoring Committee (DMC), die NOSTRA-III-Studie ...

vasopharm Closes Series F Financing Round - openPR

www.openpr.com

Press release - vasopharm GmbH - vasopharm Closes Series F Financing Round - published on openPR.com

vasopharm Closes €9.5 Million Financing Round | Markets InsiderBusiness Insider

markets.businessinsider.com

Christian Wandersee, Chief Executive Officer of vasopharm, commented: "Following the DMC recommendation to continue the NOSTRA III trial as per protocol, we ... Christian Wandersee, Chief Executive Officer of vasopharm, commented: "Following the DMC recommendation to continue the NOSTRA III trial as per protocol, we ...

vasopharm Closes €9.5 Million Financing RoundMedindia

www.medindia.net

— Christian Wandersee, Chief Executive Officer of vasopharm, commented: "Following the DMC recommendation to continue the NOSTRA III trial as — Christian Wandersee, Chief Executive Officer of vasopharm, commented: "Following the DMC recommendation to continue the NOSTRA III trial as ...

vasopharm BIOTECH GmbH Closes Series F Financing RoundBioSpace

www.biospace.com

... Christian Wandersee, CEO of vasopharm. “In the Phase IIa NOSTRA trial, we ... Christian Wandersee, CEO vasopharm GmbH. Phone: + Email Christian Wandersee, CEO of vasopharm. “In the Phase IIa NOSTRA trial, we ... Christian Wandersee, CEO vasopharm GmbH. Phone: + Email ...

vasopharm closes EUR9.5m financing roundPrivate Equity Wire

www.privateequitywire.co.uk

Christian Wandersee, Chief Executive Officer of vasopharm, says: “Following the DMC recommendation to continue the NOSTRA III trial as per protocol, we are ... Christian Wandersee, Chief Executive Officer of vasopharm, says: “Following the DMC recommendation to continue the NOSTRA III trial as per protocol, we are ...

Updates: vasopharm Closes € 9.5 million Financing RoundCreathor Ventures

www.creathor.com

— Christian Wandersee, Chief Executive Officer of vasopharm, commented: “Following the DMC recommendation to continue the NOSTRA III trial as — Christian Wandersee, Chief Executive Officer of vasopharm, commented: “Following the DMC recommendation to continue the NOSTRA III trial as ...

vasopharm Closes Series F Financing Round - Bayerns Investor für …

bayernkapital.de

Web”VAS203 has demonstrated safety and tolerability in two clinical Phase I studies with single and repetitive dosing schedules,” added Christian Wandersee, CEO of vasopharm. “In …

Alle Infos zum Namen "Christian Wandersee"

Verwandte Suchanfragen zu Christian Wandersee

Ulrich Walter
Mary Clark
Frank Tegtmeier

Jana Fritz
Stefan Haupt
Peter Voll

Gabriele Wandersee
Klaus Wandersee
Guido Stalszus

Personen
Vorname "Christian" (95886)
Name "Wandersee" (49)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Christian Wandersee und Financing Person-Info